Publications for Jay H. Shubrook jay.shubrook@tu.edu

Casapulla, S. L., Howe, C. A., Mora, G. R., Berryman, D., Frijalva, M. J., Rojas, E. W., . . . Shubrook, J. H. (2017). Cardiometabolic risk factors, metabolic syndrome and pre-diabetes in adolescents in the Sierra region of Ecuador. Diabetology & Metabolic Syndrome, 9 [Article 24]. This material can be found here.

Chamberlain, J. J., Herman, W. H., Leal, S., Rhinehart, A. S., Shubrook, J. H., Skolnik, N., & Kalyani, R. R. (2017). Pharmacologic therapy for type 2 diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine, 166(8), 572-578. This material can be found here.

Skolnik, N., Jaffa, F. M., Kalyani, R. R., Johnson, E., & Shubrook, J. H. (2017). Reducing CV risk in diabetes: An ADA update. Journal of Family Practice, 66(5), 300-308. This material can be found here.

de Groot, M., Crick, K. A., Long, M., Saha, C., & Shubrook, J. H. (2016). Lifetime duration of depressive disorders in patients with type 2 diabetes. Diabetes Care, 39(12), 2174-2181. doi:10.2337/dc16-1145

Johnson, E., Warren, F., Skolnik, N., & Shubrook, J. H. (2016). Diabetes update: Your guide to the latest ADA standards. Journal of Family Practice, 65(5), 310-318. This material can be found here.

Morris, M. R., Ludwar, B. C., Swingle, E., Mamo, M. N., & Shubrook, J. H. (2016). A new method to assess asymmetry in fingerprints could be used as an early indicator of type 2 diabetes mellitus. Journal of Diabetes Science and Technology, 10(4), 864-871. doi:10.1177/1932296816629984

Young, C. F., Dugan, J. A., Pfotenhauer, K., & Shubrook, J. H. (2016). Pharmacologic management of diabetes mellitus: Part 1. Primary Care Reports, 22(10), 117-127. This material can be found here.

Young, C. F., Dugan, J. A., Pfotenhauer, K., & Shubrook, J. H. (2016). Pharmacologic management of type 2 diabetes mellitus: Part 2. Primary Care Reports, 22(11), 129-138. This material can be found here.

Ciervo, C. A., Shubrook, J. H., & Grundy, P. (2015). Diabetes management within evolving health care delivery models: The osteopathic perspective [Supplemental material]. Journal of the American Osteopathic Association, 115, eS5-eS7. This material can be found here.

Ciervo, C. A., Shubrook, J. H., & Grundy, P. (2015). Leveraging the principles of osteopathic medicine to improve diabetes outcomes within a new era of health care reform [Supplemental material]. Journal of the American Osteopathic Association, 115, eS8-eS19. This material can be found here.

de Groot, M. Shubrook, J. H., Schwartz, F., Hornsby Jr., W. G., Pillay, Y., & Saha, C. (2015). Program ACTIVE II: Design and methods for a multi-center community-based depression treatment for rural and urban adults with type 2 diabetes. Journal of Diabetes Research and Therapy, 1(2). This material can be found here.

Gehlaut, R. R., Dogbey, G. Y., Schwartz, F. L., Marling, C. R., & Shubrook, J. H. (2015). Hypoglycemia in type 2 diabetes - More common than you think: A continuous glucose monitoring study. Journal of Diabetes Science and Technology, 9(5), 999-1005. doi:10.1177/1932296815581052

Lavernia, F., Adkins, S. E., & Shubrook, J. H. (2015). Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals. Postgraduate Medicine, 127(8), 808-817. doi:10.1080/00325481.2015.1085293

Miller, E., & Shubrook, J. H. (2015). Sodium glucose co-transporter 2 inhibitors in the treatment of Type 2 diabetes mellitus. Osteopathic Family Physician, 7(5), 10-30. This material can be found here.

Millstein, R., Becerra, N. M., & Shubrook, J. H. (2015). Insulin pumps: Beyond basal-bolus. Cleveland Clinic Journal of Medicine, 82(12), 835-842. This material can be found here.

Presswala, L., & Shubrook, J. H. (2015). What to do after basal insulin: 3 Tx strategies for type 2 diabetes. Journal of Family Practice, 64(4), 214-220. This material can be found here.

Shubrook, J. H., Bokaie, B. B., & Adkins, S. E. (2015). Empagliflozin in the treatment of type 2 diabetes: Evidence to date. Drug Design, Development and Therapy, 9, 5793-5803. doi:10.2147/DDDT.S69926

Shubrook, J. H., Brown, H., Lang, M., & Berryman, D. (2015). Patient preferences for diabetes education. Journal of the American Osteopathic Association, 115(12), e87-e88. This material can be found here.

Shubrook, J. H., deGroot, M., Pillay, Y., Hornsby, G., Saha, C., & Mather, K. (2015). Program ACTIVE II: Testing behavioral interventions for depression in T2DM. Journal of the American Osteopathic Association, 115(12), e100-e101. This material can be found here.

Van Ravenswaay, V. J., Hain, S. J., Grasso, S., & Shubrook, J. H. (2015). Effects of osteopathic manipulative treatment on diabetic gastroparesis. Journal of the American Osteopathic Association, 115, 452-458. doi:10.7556/jaoa.2015.091

Vogelgesang, J., Drozek, D., Nakazawa, M., & Shubrook, J. H. (2015). Payer source influence on effectiveness of lifestyle medicine programs. American Journal of Managed Care, 21(9), e503-e508. This material can be found here.

Yun, K., Dugan, J. A., Young, C. F., Parthasarathy, A., & Shubrook, J. H. (2015). Food insecurity, numeracy and literacy associations with decreased glycemic control in people with type 2 diabetes in Solano County. Journal of the American Osteopathic Association, 115(12), e108-e109. This material can be found here.